Abstract
Inhibitors of aldose reductase provide a feasible mode of action against diabetic complications. Based on the marketed aldose reductase inhibitor epalrestat containing rhodanine nucleus, rhodanine-3-hippuric acid and its 5-arylidene derivatives were synthesized. The structure of newly synthesized compounds was confirmed by IR, 1H NMR, and 13C NMR spectrometry. In vitro aldose reductase inhibitory activity of the synthesized compounds was assayed and the results showed that most of the derivatives were potent against aldose reductase with IC50 values ranging from 0.2 to 2.36 µM. Two of the compounds with the highest efficacies among the tested compounds (IC50 values of 0.2 and 0.6 µM) were more potent than epalrestat. Molecular docking studies were undertaken to explore the binding modes of all compounds into the active site of aldose reductase in order to rationalize the inhibitory efficacy of these derivatives. Rhodanine-3-hippuric acid and all its arylidene derivatives fulfil Lipinski’s rule and show good drug-likeness property. In conclusion, novel compounds synthesized in the present study have proved to be potential drugs for diabetic complications.
Similar content being viewed by others
REFERENCES
Soni, L.K., Gupta, A.K., and Kaskhedikar, S.G., Med. Chem. Res., 2008, vol. 17, pp. 258–266.
Tang, W.H., Martin, K.A., and Hwa, J., Front. Pharmacol., 2008, vol. 3, pp. 1–8.
Han, Z., Hao, X., Ma, B., and Zhu, C., Eur. J. Med. Chem., 2016, vol. 121, pp. 308–317.
Zhu, C., Diabetes Mellitus: Insights Perspect., 2013, vol. 2, pp. 17–46.
Bozdag-Dundar, O., Das Evcimen, N., Ceylan-Unlusoy, M., Ertan, R., and Sarikaya, M., Med. Chem. Res., 2007, vol. 16, pp. 39–47.
Carper, D.A., Wistow, G., Nishimura, C., Graham, C., Watanabe, K., Fujii, Y., Hayashi, H., and Ayaishi, O.A., Exp. Eye Res.,1989, vol. 49, pp. 377–388.
Jez, J.M., Bennett, M.J., Schlegel, B.P., Lewis, M., and Penning, T.M., Biochem. J., 1997, vol. 326, pp. 625–636.
Demopoulos, V.J., Zaher, N., Zika, C., Anagnostou, C., Mamadou, E., Alexiou, P., and Nicolaou, I., Drug Design Rev. Online, 2005, vol. 2, pp. 293–304.
Ramunno, A., Cosconatid, S., Sartini, S., Maglio, V., Angiuoli, S., Pietra, V.L., Maro, S.D., Giustiniano, M., Motta, C.L., Settimo, F.D., Marinelli, L., and Novellino, E., Eur. J. Med. Chem., 2012, vol. 51, pp. 216–226.
Kador, P.F., Kinoshita, J.H., and Sharpless, N.E., J. Med. Chem., 1985, vol. 28, pp. 841–849.
Suzen, S. and Buyukbingol, E., Curr. Med. Chem., 2003, vol. 10, pp. 1329–1352.
La Motta, C., Sartini, S., Simorini, F., Taliani, S., Marini, A.M., Da Settimo, F., Marinelli, L., Limongelli, V., and Novellino, E., J. Med. Chem., 2008, vol. 51, pp. 3182–3193.
Chen, X., Zhu, C., Guo, F., Qiu, X., Zhang, S., He, M., Praveen, S., Jing, C., Liu, Y., and Ma, B., J. Med. Chem., 2010, vol. 53, pp. 8330–8344.
Chen, X., Yang, Y., Zhu, C., Gui, D., Hussain, S., Qiu, X., Zhang, S., He, M., Jing, C., Liu, Y., and Ma, B., Eur. J. Med. Chem., 2011, vol. 46, pp.1536–1544.
Hamada, Y. and Nakamura, J., Treat. Endocrinol., 2004, vol. 3, pp. 245–255.
Costantino, L., Vianello, P., Rastelli, G.V., Cignarella, G., and Barlocco, D., Med. Res. Rev., 1999, vol. 19, pp. 3–23.
Urzhumtsev, A., Tete-Favier, F., Mitschler, A., Barbanton, J., Barth, P., Urzhumtseva, L., Biellmann, J.F., Podjarny, A.D., and Moras, D., Structure, 1997, vol. 5, pp. 601–612.
Jaspan, J.B., Herold, K., and Bartkus, C., Am. J. Med., 1985, vol. 79, pp. 24–37.
Miwa, I., Hirano, M., Inagaki, K., Belbeoch, C., and Okuda, J., Biochem. Pharmacol., 1987, vol.36, pp. 2789–2794.
Miwa, I., Hirano, M., Kanbara, M., and Okuda, J., Biochem. Pharmacol., 1990, vol. 40, pp. 303–307.
Barakat, A., Al-Majid, A.M., AL-Najjar, H.J., Mabkhot, Y.N., Ghabbourc, H.A., and Fun, H., RSC Adv., 2014, vol. 4, pp. 4909–4916.
Thatikonda, N.R., Ravinder, M., Pankaj, B., Ravikanti, K., Chandrakant, B., Jagadeesh, B.N., Kolupula, S., Sanjay, K.B., and Rao, V.J., Eur. J. Med. Chem., 2014, vol. 71, pp. 53–66.
Rosanna, M., Antonello del, C., Marco, G., Roberta, M., Umberto, M., and Rosaria, O., Bioorg. Med. Chem. Lett., 2011, vol. 21, pp. 200–203.
Alexiou, P., Pegklidou, K., and Chatzopoulou, M., Curr. Med. Chem., 2009, vol.16, pp. 734–752.
Stawoska I., Tejchman W., Mazuryk O., Lycka A., Nowak-Sliwinska P., Zeslawska E., and Nitek W., J. Heterocycl. Chem., 2017, vol. 54, pp. 2889–2897.
Sundaram, K. and Ravi, S., Res. Chem. Intermed., 2015, vol. 41, pp.1011–1021.
Aliya, I., Yildiz, T., Khan, I., Abdul, H., Saeed, A., Norbert, F., Bajorath, J., and Iqbal, J., Bioorg. Chem., 2016, vol. 68, pp. 177–186.
Xin, H., Zhongfei, H., Li, Y., Li, C., Wang, X., Zhang, X., Qin, Y., Ma, B., and Changjin, Z., Bioorg. Med. Chem. Lett., 2017, vol. 27, pp. 887–892.
El-Kabbani, O., Ramsland, P., Darmanin, C., Chung, R.P.T., and Podjarny, A., Proteins: Struct., Funct., Bioinf., 2003, vol. 50, pp. 230–238.
Cosconati, S., Marinelli, L., La Motta, C., Sartini, S., Da Settimo, F., Olson, A.J., and Novellino, E., J. Med. Chem., 2009, vol. 52, pp. 5578–5581.
El-Kabbani, O., Darmanin, C., Schneide, T.R., Hazemann, I., Ruiz, F., Oka, M., Joachimiak, A., Schulze-Briese, C., Tomizaki, T., Mitschler, A., and Podjarny, A., Proteins: Struct., Funct., Bioinf., 2004, vol. 55, pp. 805–813.
Kinoshita, J.H., Invest. Ophthalmol., 1965, vol. 4, pp. 786–799.
Haraguchi, H., Hayashi, R., Ishizu, T., and Yagl, A., Planta Med., 2003, vol. 69, pp. 853–855.
ACKNOWLEDGMENTS
We thank Karpagam Academy of Higher Education for providing instrumentation specialities to do the present research work. The authors are thankful to SAIF-STIC, Cochin University of Science and Technology, for their instrumentation support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
This article does not contain any studies involving human participants performed by any of the authors and does not contain any studies involving animals performed by any of the authors.
Conflict of Interest
The authors declare that they have no conflicts of interest.
Additional information
Corresponding author: e-mail: sundarg2010@gmail.com
Rights and permissions
About this article
Cite this article
Stephen Kumar Celestina, Sundaram, K. & Ravi, S. Novel Derivatives of Rhodanine-3-Hippuric Acid as Active Inhibitors of Aldose Reductase: Synthesis, Biological Evaluation, and Molecular Docking Analysis. Russ J Bioorg Chem 45, 405–415 (2019). https://doi.org/10.1134/S1068162019050066
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162019050066